Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1986 Oct;54(4):705–709. doi: 10.1038/bjc.1986.230

The effect of adjuvant cyclophosphamide or tamoxifen on the numbers of lymphocytes bearing T cell or NK cell markers.

C R Sheard, F Reilly, D E Tee, D Vergani, D Lowe, M Baum, A E Cameron
PMCID: PMC2001508  PMID: 3490874

Full text

PDF
705

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bast R. C., Jr, Reinherz E. L., Maver C., Lavin P., Schlossman S. F. Contrasting effects of cyclophosphamide and prednisolone on the phenotype of human peripheral blood leukocytes. Clin Immunol Immunopathol. 1983 Jul;28(1):101–114. doi: 10.1016/0090-1229(83)90193-9. [DOI] [PubMed] [Google Scholar]
  2. Berd D., Maguire H. C., Jr, Mastrangelo M. J. Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide. Cancer Res. 1984 Nov;44(11):5439–5443. [PubMed] [Google Scholar]
  3. Berd D., Mastrangelo M. J., Engstrom P. F., Paul A., Maguire H. Augmentation of the human immune response by cyclophosphamide. Cancer Res. 1982 Nov;42(11):4862–4866. [PubMed] [Google Scholar]
  4. Brenner B. G., Friedman G., Margolese R. G. The relationship of clinical status and therapeutic modality to natural killer cell activity in human breast cancer. Cancer. 1985 Oct 1;56(7):1543–1548. doi: 10.1002/1097-0142(19851001)56:7<1543::aid-cncr2820560713>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  5. Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at six years by Nolvadex Adjuvant Trial Organisation. Lancet. 1985 Apr 13;1(8433):836–840. [PubMed] [Google Scholar]
  6. Hansbrough J. F., Bender E. M., Zapata-Sirvent R., Anderson J. Altered helper and suppressor lymphocyte populations in surgical patients. A measure of postoperative immunosuppression. Am J Surg. 1984 Sep;148(3):303–307. doi: 10.1016/0002-9610(84)90459-8. [DOI] [PubMed] [Google Scholar]
  7. Maguire H. C., Jr, Ettore V. L. Enhancement of dinitrochlorobenzene (DNCB) contact sensitization by cyclophosphamide in the guinea pig. J Invest Dermatol. 1967 Jan;48(1):39–43. doi: 10.1038/jid.1967.6. [DOI] [PubMed] [Google Scholar]
  8. McCluskey D. R., Roy A. D., Abram W. P., Martin W. M. T lymphocyte subsets in the peripheral blood of patients with benign and malignant breast disease. Br J Cancer. 1983 Feb;47(2):307–309. doi: 10.1038/bjc.1983.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ozer H., Cowens J. W., Colvin M., Nussbaum-Blumenson A., Sheedy D. In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration. J Exp Med. 1982 Jan 1;155(1):276–290. doi: 10.1084/jem.155.1.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Röllinghoff M., Starzinski-Powitz A., Pfizenmaier K., Wagner H. Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes. J Exp Med. 1977 Feb 1;145(2):455–459. doi: 10.1084/jem.145.2.455. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES